Page Image

Nephrology Times

Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.

FDA Approves Lupin’s Generic Tolvaptan Tablets
Lupin's generic tolvaptan tablets are now FDA-approved for treating autosomal dominant polycystic kidney disease (ADPKD).
Advertisement

Latest News

Advertisement

In Print

Conferences

Podcasts

Expert Columns

Advertisement
Advertisement
Nephrology Times Chair

Editorial Board